(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.42%) $924.40
(0.38%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
4.30% HKD 35.20
Live Chart Being Loaded With Signals
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...
Stats | |
---|---|
Volumen de hoy | 9.16M |
Volumen promedio | 10.52M |
Capitalización de mercado | 125.85B |
EPS | HKD0.940 ( 2023-10-31 ) |
Last Dividend | HKD0.989 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.06 |
ATR14 | HKD0.0650 (0.18%) |
Volumen Correlación
WuXi AppTec Co., Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
WuXi AppTec Co., Ltd. Correlación - Moneda/Commodity
WuXi AppTec Co., Ltd. Finanzas
Annual | 2023 |
Ingresos: | HKD40.34B |
Beneficio Bruto: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2023 |
Ingresos: | HKD40.34B |
Beneficio Bruto: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2022 |
Ingresos: | HKD39.35B |
Beneficio Bruto: | HKD14.68B (37.30 %) |
EPS: | HKD3.15 |
FY | 2021 |
Ingresos: | HKD22.90B |
Beneficio Bruto: | HKD8.31B (36.28 %) |
EPS: | HKD1.820 |
Financial Reports:
No articles found.
WuXi AppTec Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.989 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.281 | 2019-06-17 |
Last Dividend | HKD0.989 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD2.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.38 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8371.HK | Ex Dividend Junior | 2023-08-03 | Annually | 0 | 0.00% | |
2020.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
1099.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
0168.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
3737.HK | Ex Dividend Junior | 2023-10-17 | Annually | 0 | 0.00% | |
1668.HK | No Dividend Player | 2023-09-26 | Annually | 0 | 0.00% | |
0710.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
2230.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
1243.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
0308.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.238 | 1.500 | 5.24 | 7.86 | [0 - 0.5] |
returnOnAssetsTTM | 0.130 | 1.200 | 5.65 | 6.78 | [0 - 0.3] |
returnOnEquityTTM | 0.187 | 1.500 | 9.04 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.287 | -1.000 | 7.13 | -7.13 | [0 - 1] |
currentRatioTTM | 2.06 | 0.800 | 4.69 | 3.75 | [1 - 3] |
quickRatioTTM | 1.610 | 0.800 | 5.24 | 4.19 | [0.8 - 2.5] |
cashRatioTTM | 0.933 | 1.500 | 5.93 | 8.89 | [0.2 - 2] |
debtRatioTTM | 0.0780 | -1.500 | 8.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 61.33 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 8.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.104 | -1.500 | 9.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.47 | 6.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.294 | 1.000 | 6.11 | 6.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.18 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.548 | 0.800 | 9.68 | 7.75 | [0.5 - 2] |
Total Score | 12.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.12 | 1.000 | 9.08 | 0 | [1 - 100] |
returnOnEquityTTM | 0.187 | 2.50 | 9.38 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 9.22 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.04 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.287 | 1.500 | 7.13 | -7.13 | [0 - 1] |
pegRatioTTM | 0.503 | 1.500 | 9.98 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.311 | 1.000 | 4.74 | 0 | [0.1 - 0.5] |
Total Score | 7.38 |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico